Titan Pharmaceuticals
TTNP
#11024
Rank
โ‚น0.58 B
Marketcap
โ‚น440.62
Share price
-3.76%
Change (1 day)
25.69%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น419.60. In 2023 the company made an earnings per share (EPS) of -โ‚น708.25 an increase over its 2022 EPS that were of -โ‚น1,452.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น708.25-51.22%
2022-โ‚น1,452-15.61%
2021-โ‚น1,720-81.37%
2020-โ‚น9,233-77.52%
2019-โ‚น41,080-56.32%
2018-โ‚น94,052-59.51%
2017-โ‚น2,32,308-371.81%
2016โ‚น85,466-144.35%
2015-โ‚น1,92,691300%
2014-โ‚น48,173-121.54%
2013โ‚น2,23,659-151.38%
2012-โ‚น4,35,275-11.54%
2011-โ‚น4,92,050188.89%
2010-โ‚น1,70,325-10%
2009-โ‚น1,89,250
2007-โ‚น7,75,925-2.38%
2006-โ‚น7,94,850-39.13%
2005-โ‚น13,05,826-16.87%
2004-โ‚น15,70,776-22.43%
2003-โ‚น20,24,9764.9%
2002-โ‚น19,30,35161.9%
2001-โ‚น11,92,276-13.7%
2000-โ‚น13,81,52665.01%
1999-โ‚น8,37,251-35.87%
1998-โ‚น13,05,603-1824.71%
1997โ‚น75,700-102.4%
1996-โ‚น31,60,477

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น834.86-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น670.97-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น387.10-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.93-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.94-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น407.17-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA